PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, United States.\', \'Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, United States.\', \'Department of Internal Medicine, University of Michigan, Ann Arbor, MI, United States.\', \'Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States.\', \'Division of Infectious Diseases, Department of Internal Medicine, and the Programs in Immunology, Cellular and Molecular Biology, and Cancer Biology, University of Michigan, Ann Arbor, MI, United States.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3389/fimmu.2021.763460
?:doi
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 35003077
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • Glycoprotein Targeted CAR-NK Cells for the Treatment of SARS-CoV-2 Infection.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all